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Retroviruses are ubiquitous agents present in wild mice as well as inbred laboratory 
mice. They occur as endogenous proviruses and are transmitted vertically through 
the germ line ceils (1, 2). Although they are present in the DNA of all the cells in the 
form of integrated  provirus,  their  regulation  is  under  strict  control  and  they are 
strongly repressed in most tissues.  These viruses, however, can be expressed naturally 
late in life in mice with certain genetic dispositions (3, 4). Their expression, though, 
is under genetic and developmental control and is often confined to the hemopoietic 
tissues, notably the cells in the bone marrow, spleen, and the thymus (2, 5-7).  The 
expression of these viruses and their genes in these mice in some cases is associated 
with a variety of hemopoietic disorders such as autoimmune disease (8), lymphomas, 
and leukemias (3, 4).  In some instances, infectious retroviruses have been recovered 
from these diseased animals, and these are capable of inducing hemopoietic aberra- 
tions similar to those in the diseased mice from which the viruses were isolated (5, 9- 
11). Viral induced modification of hemopoietic differentiation is thus well established. 
To understand the relationship between normal and virally induced hemopoietic 
differentiation and the genetic control of these processes, much effort has been devoted 
to the in vitro and in vivo studies of these events. The best-studied viral modified 
hemopoietic system is probably Friend erythroleukemia. Friend erythroleukemia virus 
(FLV), 1 isolated  in  1957 by Charlotte  Friend  (9),  is  a  complex of two  viruses, a 
replication-defective, erythroleukemia-inducing, spleen  focus-forming virus  (SFFV) 
(12)  and  a  replication-independent  leukemia  virus  (F-MuLV)  that  provides  the 
necessary function for SFFV to complete its replicative cycle (13,  14). Subsequent to 
infection with FLV, susceptible adult and newborn mice develop very rapid (1-3 wk) 
erythropoietic changes including splenomegaly (9, 15) and development of anemia or 
polycythemia, depending on whether the anemia strain (FV-A)  (9) or the polycythe- 
mia  strain  (FV-P)  (16)  is  used.  This  induction  of early  polycythemia by  FV-P, 
however, has recently been shown to be  mouse strain dependent  (16),  for whereas 
severe  polycythemia is  induced  early in  the  mouse strains  DBA/2,  BALB/c, and 
AKR, rapid anemia is induced in mouse strains CBA and C3H (16). 
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In addition  to pathological changes, the FLV complexes also induce rapid hemo- 
poietic changes, notably in the progenitor cells in the erythroid pathways. The most 
dramatic change is the increase in colony-forming unit-erythroids (CFU-E*) 2 (17-19). 
In addition, differences in the nature and frequencies of erythroid progenitor cells can 
also be detected in mice infected with the two strains of FLV. For example, whereas 
the proliferation and differentiation of CFU-E* in FV-A-infected mice are still under 
the  control  of  erythropoietin  (epo)  (19,  20),  erythropoiesis  and  development  of 
CFU-E*  in FV-P-infected mice are independent  of epo (17-19,  21, 22).  These rapid 
erythropoietic  modulations  are  functions  of the  SFFV  components  (19),  and  little 
change can  be detected  when  the helper  virus F-MuLV alone is injected  into adult 
susceptible mice. 
Several reports  (20, 23-25), however, indicate that when newborn BALB/c or NIH 
Swiss  mice  are  used,  the  replication-independent  F-MuLV,  which  has  often  been 
considered's simply the helper virus, can also induce splenomegaly. In this study, we 
examinedthe  modulation  of erythropoiesis by the replication-independent  F-MuLV 
in newborn and adult  mice. 
Materials  and Methods 
Virus.  An NB-tropic Friend F-MuLV was cloned from a FV-P complex by limiting dilution 
(14). This virus has been shown repeatedly over the last 5 yr (14, 19, 20, 26) by both biochemical 
and biological methods to contain no detectable SFFV. Titer of the F-MuLV was determined 
by the XC plaque assay (27). 
Mice.  BALB/c and DBA/2 mice were obtained from The Jackson Laboratory (Bar Harbor, 
ME). Newborn BALB/c mice were obtained from the Ontario Cancer Institute Animal Colony. 
Culture of Progenitor Cell Colonies 
CFU-E  AND  ERYTHROID  BURST  (BFU-E)  ASSAY.  CFU-E and  BFU-E progenitor colony assays 
were performed as described previously (19, 28). In brief, bone marrow cells were obtained by 
flushing femurs with a-medium. Spleen cell suspensions were made by pressing spleen fragments 
with glass slides. After washing with a-medium, the bone marrow or spleen cells were plated in 
1 ml of 0.8%  methylcellulose in a-medium or Iscove's modified Dulbecco's medium supple- 
mented with 7.5 ×  l0  -5 M  2-mercaptoethanol,  1% deionized bovine serum albumin, and 30% 
fetal calf serum  (Flow Laboratories, Inc., Rockville, MD).  Erythropoietin  (step  III, lot  3038; 
Connaught Laboratory) was added at a final concentration of 0.2-2.0 U/ml for CFU-E or for 
BFU-E colony assays. Colonies containing 8-64 hemoglobinized cells at day 2 were counted as 
CFU-E or CFU-E*, and clusters of three or more colonies were counted as BFU-E or BFU-E* 
at day 7. 
Results 
To examine changes in the hemopoietic progenitor cells, 1-d-old BALB/c mice were 
infected with 3 ×  105 XC plaque U  of F-MuLV. 7 wk after infection, the spleens and 
marrow cells were obtained from these infected mice and the frequencies of CFU-E* 
and BFU-E* were measured.  These results were compared with those obtained from 
uninfected  BALB/c  mice.  Results  in  Table  I  indicate  that  whereas  the  levels  of 
CFU-E and BFU-E in the spleens and marrows of the uninfected mice are consistent 
with  those  reported  previously  for  normal  mice,  changes  in  the  erythroid  bursts 
colonies can be detected in the spleens and marrows of the mice infected by F-MuLV. 
Unlike mice infected with the FLV complexes, BALB/c mice infected by F-MuLV 
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TABLE  I 
BFU-E and CFU-E in Spleens and Marrows of Uninfected BALB/c Mice and BALB/c Mice Infected 
with F-MuL V as Newborns 
CFU-E/10 s cells  BFU-E/10  5 cells 
-epo  +0.5 epo  -epo  +2.0 epo 
Uninfected  Marrow  0  141.3 ± 2.5  0  7 + 0.8 
Spleen  0  36.7 ± 3.8  0  2.9 ± 0.8 
CFU-E*/10  8 cells  BFU-E*/IO  s cells 
Infected as newborn  Marrow  0  114.7 +  13.5  0  223 + 50 
with F-MuLV  Spleen  0  16 ± 3.5  0  1258 ±  121 
Spleen and marrow cells were obtained from normal 7-wk-old BALB/c mice or 7-wk-otd BALB/c mice 
infected with 3 X l0  s XC plaque U of F-MuLV at the time of birth. The cells were washed and plated for 
CFU-E or CFU-E* and BFU-E or BFU-E* as described in Materials and Methods. CFU-E* and BFU-E* 
denote CFU-E and BFU-E-like  colonies in the virally infected animals. Data are expressed as number of 
colonies per 105 nucleated cells. At least four plates were used in each determination. 
as newborns did not have dramatic increase in the level of either epo-dependent or 
-independent CFU-E*  in  the  spleen  or  marrow  (possibly even  a  slight  decrease). 
Instead, there was a  dramatic increase in the levels of BFU-E-like colonies. This level, 
which reached ~ 1,500 bursts/105 cells or ~5 ×  10  v BFU-E*/spleen was much higher 
than those reported (29)  for mice infected with the FLV complexes (T. Shibuya and 
T. W. Mak, unpublished observations). A similar picture was seen in the bone marrow 
of F-MuLV-infected mice, with ~300 BFU-E*/105 cells or 3 ×  105 cells/femur. These 
F-MuLV-induced BFU-E*  colonies  were  similar  in  size  and  morphology  to  the 
BFU-E colonies in uninfected animals (Fig.  1). However, they differ from the normal 
BFU-E in that they contained less hemoglobinized cells per colony. To demonstrate 
that these BFU-E* were erythroid in nature, 20 colonies were picked and stained for 
spectrin-positive cells by  immunofluorescence as  described previously (24).  Results 
showed  that  >99%  of  the  cells  contained  the  erythroid-specific  marker  spectrin, 
confirming the erythroid nature of these BFU-E*. Although a  high level of erythroid 
bursts (200-300 BFU-E*/105 cells) were observed, the number of CFU-E*/105 cells in 
the marrow and spleens was unchanged or slightly reduced. The formation of these 
erythropoietic progenitor cells was  dependent on  epo,  as  no  erythroid  colonies or 
erythroid bursts could be detected in the absence of the hormone. 
Epo  Requirement in  the Erythroid  Progenitor Colonies (CFU-E and BFU-E)  in  F-MuL V- 
infected Mice.  The  level of epo  required  for  the  formation of erythroid progenitor 
colonies BFU-E*  and CFU-E*  in mice infected with F-MuLV was  also examined. 
Cells from the marrow and spleens of infected animals were obtained at  7 wk after 
infection, and the levels of CFU-E* and BFU-E* were determined in the absence of 
any added epo and in the presence of varying amounts of added epo. The results of 
such experiments are illustrated in Figs. 2 and 3. As in the results described above, the 
spleen  cells  contained  a  high  level  of  erythroid  bursts  and  their  formation  was 
dependent  on  added  epo.  The  data  in  Fig.  2  show  that  the  number of BFU-E* 
increased with added epo and reached a plateau of ~ 1,200-1,500 BFU-E*/105 spleen 
cells at 0.2 U  of epo/plate and ~500 BFU-E*/105 marrow cells at  ~1.0 U/plate of 
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Fro.  1.  Colony  morphology  of erythroid  bursts  from  spleens  of BALB/c  mice  infected  with 
F-MuLV  as  newborn  or  uninfected  BALB/c mice.  Spleen  cells  were  obtained  from  7-wk-old 
BALB/c  mice  infected  with  3  ×  105  XC  plaque  U  of F-MuLV  (upper  panel)  or  uninfected 
BALB/c mice (lower panel) and cultured for erythroid bursts  in the presence of 2.0 U/plate of epo 
as described in Materials and Methods. 
F-MuLV-infected  spleen  and  marrow  cells are  illustrated  in  Fig.  3.  As can  be seen, 
the  formation  of CFU-E*  in  the  spleen  and  marrow  cells  in  mice  infected  with  F- 
MuLV  as newborns  was also dependent  on the addition of epo. Similar to the results 
above, the number  of CFU-E*  in the F-MuLV-infected  spleen cells was low, reaching 
a  level of-50  CFU-E*  at  as low as 0.2  U  of epo/plate.  The  level of CFU-E*  in  the 150  MODULATION OF  ERYTHROPOIESIS  BY  FRIEND  LEUKEMIA VIRUS 
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F~G.  2.  Epo dose-response  curves of BFU-E* from the spleens and marrow cells of BALB/c mice 
infected at birth with F-MuLV. BALB/c mice were infected at birth with 3 ×  105 XC plaque U of 
F-MuLV. 7 wk after infection,  the mice were killed and the spleen cells (0) and marrow cells (O) 
plated for BFU-E in a-medium at 0, 0.2, 0.5.  1.0, and 2.0 U ofepo per plate. 
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marrow  cells  increased  to  a  plateau  of ~250  CFU-E*/105  cells  at  ~0.5  U  of epo/ 
plate.  For comparison purposes, dose-resonse curves for BFU-E and CFU-E  in normal 
uninfected  BALB/c  mouse marrow are also summarized  in  Fig. 4. 
Modulation  of  E~ythropoiesis  in  Adult  Mice  by  F-MuL V  and  Phenylhydrazine 
(PHZ).  Results described above and elsewhere (13, 20, 30)  indicate that  injection of 
F-MuLV  alone  into  adult  mice  results  in  little  or  no  erythropoietic  changes  or 
splenomegaly.  Modulation  of the erythropoietic changes  in adult  mice, however, can 
be induced  by the addition  of certain chemicals like PHZ.  Furthermore,  Tambourin 
et  al.  (31)  have  shown  that  administering  the  polycythemia  FLV  complex  in  con- 
junction  with  PHZ  resulted  in  an  accelerated  disease.  In  a  study  similar  to  those 
described by S. Ruscetti and E. Scolnick (unpublished observation), we have examined 
FtG.  3.  Epo dose-response  curves for CFU-E* in BALB/c mice infected at birth with F-MuLV. 
Spleen cells  (0)  and  marrow cells  (0)  were obtained  as described  in  Fig.  2,  and  CFU-E* were 
measured at 0, 0.2, 0.5, 1.0, and 2.0 U of epo/plate. In this experiment, Iscove's modified Dulbecco's 
medium was used. Y.  NIHO, T.  SHIBUYA, AND  T.  W.  MAK  151 
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FIe.  4.  Epo dose-response curves for BFU-E and CFU-E in uninfected BALB/c mice.  BALB/c 
mice at  7 wk old were killed,  and the bone marrow cells  were plated for BFU-E (upper panel) or 
CFU-E  (lower  panel)  in  the  presence  of either  Iscove's  modified  Dulbecco's  medium  (C)) or 
a-medium (0) as described in Materials and Methods. 
whether F-MuLV can affect the erythropoiesis changes  in adult  mice treated with 
PHZ. 
To this end, adult mice (8 wk old) were injected with one of the following: (a)  1.5 
×  106 XC plaque U  of cloned F-MuLV alone (time 0);  (b) 40 #g PHZ/gram at the 
following times:  1 and 2 d before time 0;  1, 2, 3, 8, 12, 16, 20, 22, and 26 d after time 
0; (c)  1.5 X  106 XC U  of F-MuLV at time 0 with PHZ regiment as in (b); (d) 2 X  103 
SFFV U  of FV-P and the PHZ regiment at times -2, -1,  1, 2, and 3 d with respect 
to time 0.  At  various times after the administration  of these viruses and  PHZ, the 
spleen weights, hematocrits, and  number of CFU-E  in the spleens of of these mice 
were measured. Results of these experiments are summarized in Fig. 5. As can be seen 
in Fig. 5  (upper panel), only a  sight increase in spleen weights could be detected in 
these adult mice infected with F-MuLV alone. With the administration of PHZ there 
was  a  moderate increase in spleen weights from ~0.1  to -0.3  g/spleen. This slight 
splenomegaly was maintained until the administration of PHZ ceased at 4 wk. When ]52  MODULATION  OF  ERYTtIROPOIESIS  BY  FRIEND  LEUKEMIA VIRUS 
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Fic.  5.  Modulation of spLeen weights and hematocrits ofaduh BALB/c mice with F-MuLV, PHZ, 
F-MuLV with PHZ, or FV-P with PHZ. 8-wk-old BALB/c mice were injected with the following: 
(a)  1.5 X 106 XC-plaque U of F-MuLV (V); (b) 40/~g/g PHZ at the times indicated by arrows at 
the top of the figure (I); (c) F-MuLV with PHZ as in (b) (0);  (d) 2 X 103 SFFV U of FV-P with 
P[IZ as in (b)  (A). At weekly intervals, the spleen weights (upper panel); or hematocrits (lower 
panel) of these mice were measured. 
the F-MuLV was injected in conjunction with the administration of PHZ, however, 
a  dramatic  increase  in  spleen  weight  up  to  ~1  g/spleen  was  detected  by  3  wk, 
indicating that  the F-MuLV could increase the splenomegaly of PHZ-treated mice. 
Mice infected with FV-P along with PHZ as controls also developed splenomegaly. 
The kinetics of changes in hematocrit values of mice given the different treatments 
are  illustrated  in  Fig.  5,  lower  panel.  Results  showed  that  there  were  only slight 
changes  in  the  hematocrit  values  in adult  mice  infected with  F-MuLV.  With  the 
administration of PHZ,  there  was  a  moderate  drop  in  the  level of hematocrits  to 
-40% at  4  wk after administration of the chemical. However, with the injection of 
F-MuLV and PHZ, there was a  gradual decrease in the level of hematocrit to ~25% 
by 4 wk. This level of hematocrit recovered to normal values only after the adminis- Y.  NIHO, T.  SHIBUYA,  AND T.  W.  MAK  153 
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Fro. 6.  CFU-E*  in adult BALB/c mice injected with F-MuLV, PHZ, F-MuLV with  PHZ, or 
FV-P with PHZ. 8-wk-old BALB/c mice were injected with F-MuLV (V, Ez), PHZ (R, []); F-MuLV 
with  PHZ  (0,  O);  or FV-P with  PHZ  (&,  A)  as  described  in  Fig.  5.  At  1 and  3 wk after 
administrations  of these statements,  the spleen cells of these mice were plated for CFU-E* in the 
presence (solid symbols) or absence (open symbols) of 0.5 U of epo/plate. The results are expressed 
as the number of CFU-E* per 105 nucleated  cells (upper panel) or number of CFU-E* per spleen 
(lower panel). 
tration of PHZ  ceased. With the administration of PHZ  and  FV-P, the hematocrit 
values dropped after  1 wk,  but  reversed and  rose to a  level of ~65%  by 3  wk.  The 
levels of erythroid progenitor cells in these adult mice under the different treatments 
were also monitored. 
The number of CFU-E* in the spleens of these mice was measured before infection 
and  at  1 and  3  wk  after  initiation of infection.  Results  in  Fig.  6,  upper and  lower 
panels, indicate that with the injection of F-MuLV  there was a  moderate increase in 
the number of CFU-E*. All the CFU-E*  were epo dependent.  With the administra- 
tion  of PHZ,  the  level  of CFU-E*  increased  to  ~3,000/10 ~ spleen  ceils or  107  per 
spleen 3 wk later. The majority of these erythroid progenitor cells were also dependent 
on  the  addition  of  epo.  The  level  of  CFU-E*,  however,  increased  further  when 
F-MuLV and PHZ were administered. These erythroid colonies, which were also epo- 
dependent,  increased to  ~4,500/105  cells or ~4  ×  107 CFU-E*/spleen.  When  FV-P 
and PHZ were injected, there was a  dramatic increase in the levels of CFUoE* in the 
spleens. These  CFU-E*  were,  however,  independent  of epo.  Experiments  similar to 
those described here with F-MuLV and PHZ were also performed in adult (8 wk old) 
DBA/2  mice.  Results  indicated  that  like  those  in  BALB/c  mice,  the  injection  of 
F-MuLV into PHZ treated mice also induced splenomegaly, a decrease in hematocrits, 
and enhancement  of levels of CFU-E*. 154  MODULATION OF  ERYTHROPOIESIS  BY  FRIEND  LEUKEMIA  VIRUS 
Discussion 
The present study confirms and extends earlier findings (20,  23-25)  that F-MuLV, 
which is often presumed not to play an important role in Friend disease, can induce 
erythropoietic changes in  newborn BALB/c mice. In addition,  it was shown that if 
the  hemopoietic component  was  perturbed  by  PHZ,  F-MuLV  can  also  modulate 
erythropoiesis in adult mice. The erythropoietic pertubations by F-MuLV in newborn 
mice, however, are different from those described before for the infection by the FLV 
complexes. It was reported that subsequent to infection by FLV complexes, a dramatic 
increase  (up to 5,000-fold/spleen)  in CFU-E*  was observed  (17-22).  In addition,  it 
was  determined  that  the  nature  of these  CFU-E*  in  the  FV-A-  or  FV-P-infected 
spleens was different. Whereas the proliferation and differentiation of CFU-E* in FV- 
A-infected  mice  are  still  under  the  control  of  epo  (19,  20),  erythropoiesis  and 
development of CFU-E* in FV-P-infected mice are independent of the hormone (17- 
19, 21, 22). It was reported that changes in the erythroid bursts can also be detected 
in  response of FLV  infection  both  in  vivo  (29)  and  in  vitro  (32,  33).  However, as 
noted in these mice infected in vivo by the FLV, the enhancement  of the erythroid 
bursts  was  insignificant  when  compared  with  the  dramatic  increase  in  CFU-E*. 
Although the CFU-E* increase in the FLV-infected spleens can be as much as 5,000 
times/spleen, the elevation in BFU-E* in the infected spleens was only ~20-30-fold/ 
spleen  (28,  29).  This  increase  in  BFU-E*  could  be partially  accounted  for by the 
dramatic increase in spleen weights of these mice. 
In  the  present  study,  we  have  shown  that  subsequent  to  F-MuLV  infection  in 
newborn BALB/c mice, a very different picture was observed. Instead of the increase 
in  CFU-E*  observed in  FLV-infected mice, a  dramatic elevation in  the number of 
BFU-E*  was observed in the spleens and marrows of mice infected by F-MuLV as 
newborns. This increase of BFU-E* in the spleens can reach a  level of ~3,000 times 
that  of the normal BFU-E in uninfected spleens. The number of CFU-E*  however, 
did not increase in these F-MuLV-infected mice. This finding suggests that the epo- 
dependent erythroid colonies observed earlier (20)  were BFU-E* and not CFU-E*. It 
is possible that because the erythroid colonies in the earlier report (20) were evaluated 
only on day two, the colonies scored were those destined to be BFU-E*. 
Although these F-MuLV BFU-E* resemble the normal bursts, it is not clear how 
similar they are to the normal day 7 BFU-E reported by Axelrad et al.  (34) or to the 
erythroid bursts induced by FLV complexes in vivo (29) and in vitro (32, 33). At least 
one minor difference from the normal BFU-E can be detected. When compared with 
the normal BFU-E under the experimental conditions described here, these F-MuLV- 
induced BFU-E* colonies contained less hemoglobinized cells. 
At this time it is not clear why F-MuLV can induce these erythropoietic changes in 
newborn BALB/c mice but not in adults. Ruscetti et al. (35)  have recently suggested 
that the ability to induce these erythropoietic changes may be related to the release 
of a virus, termed mink cell focus-forming virus. Another reason may be related to the 
nature of the hemopoietic compartment of the newborn mice, which is known to be 
more active, and different  from that of adult mice (36).  The possibility that a  more 
active hemopoietic compartment may be more susceptible to infection and modulation 
by F-MuLV is also supported by our findings. We have shown that if the hemopoietic 
compartment of adult mice is perturbed by treatment with PHZ, splenomegaly can 
be induced by infection with F-MuLV. This finding was first observed by S. Ruscetti, Y.  NIHO,  T.  SHIBUYA,  AND  T.  W.  MAK  155 
T. Feild,  L. Davis, and A. Oliff (unpublished observations). In the present study we 
have confirmed this finding and extended it to other erythropoietic changes, including 
the  induction  of anemia and  the enhancement  of CFU-E*.  It is possible that  after 
treatment  with  PHZ,  a  chemical  known  to  induce  anemia  (31),  the  hemopoietic 
tissues will regenerate and  the immature hemopoietic cells,  including  the erythroid 
precursor cells, will cycle more actively. This cycling of the erythroid precursor cells 
may render the mouse more susceptible to infection by F-MuLV. The hypothesis that 
cycling of cells  may be  important  for infection  and  transformation  has  previously 
been proposed, first by Humphries and Temin (38)  and more recently by Suzuki and 
Axelrad (36)  and Oliff et al.  (38). 
On the basis of data reported previously (20, 23-25)  and this communication, it is 
not  possible  to  determine  the  target  cell(s)  for  infection  or  transformation  by 
F-MuLV, nor is it possible to determine the relative stage of differentiation of these 
F-MuLV-transformed  cells  with  respect  to  those  induced  by  the  FV-A  or  FV-P 
complexes. Based on the finding herein that a dramatic enhancement of BFU-E* was 
observed in these F-MuLV-infected spleens with no increase in the levels of the more 
mature CFU-E*,  as in  the case of the FV-A- and  FV-P-infected mice (17-20),  it is 
tempting to postulate that the F-MuLV-transformed cells are less differentiated than 
those from the FV-A- or FV-P-infected spleens. Support of this hypothesis can also be 
found in the study of the recently established Friend erythroleukemic cell (FLC) lines 
from the F-MuLV-infected spleens (24, 38). It was determined that whereas FLC lines 
established  from FV-P-infected spleens contain  a  high  level of spectrin- and  a  low 
level of benzidine-positive cells (39), FLC lines from F-MuLV-infected newborn mice 
contain only spectrin-positive cells, but no benzidine-positive cells (24). Furthermore, 
it  was  found  that  although  FLC  lines  established  from  FV-A  and  FV-P  infected 
spleens  respond  to  epo or  dimethylsulphoxide  (DMSO)  to  differentiate  along  the 
erythroid pathway (39),  FLC lines from F-MuLV-infected mice will not respond to 
induction  by DMSO  (24,  40)  epo (24), or other commonly used inducers  (38).  The 
finding that a dramatic elevation of BFU-E* with no increase in CFU-E* also suggests 
that the leukemic block induced  by F-MuLV  infection may be between that of the 
BFU-E  and  CFU-E.  Furthermore,  these  data  would  suggest  that  the  target  cell(s) 
may be at the level of BFU-E or earlier. Alternatively, F-MuLV may infect and/or 
transform cells that in turn release or induce factors that can affect a more immature 
erythroid subpopulation(s). 
Summary 
Friend leukemia virus (FLV)  is a  complex of two viruses, a  defective spleen focus- 
forming component (SFFV) and a helper-independent virus, F-MuLV. Although the 
effects of the erythropoietic changes in susceptible adult mice after infection of FLV 
have been attributed  to the SFFV component, it has been shown that the F-MuLV 
alone can induce certain erythropoietic changes in susceptible newborn mice. In the 
present study, we have shown that very different erythropoietic changes were observed 
after  infection  with  F-MuLV.  Unlike  the  FLV  complexes,  the  F-MuLV  did  not 
induce in newborn BALB/c mice an increase in the erythroid progenitor cells (CFU- 
E*).  Instead,  a  dramatic  increase  in  the  bursts  (BFU-E*)  can  be  detected  in  the 
infected  spleens  and  marrows.  The  frequency  of BFU-E*  in  the  infected  spleens 
increased to a  level of ~ 1,500/105 cells or 5 ×  10V/spleen. In the marrows, frequency 156  MODULATION OF ERYTHROPOIESIS BY FRIEND LEUKEMIA VIRUS 
increased  to  a  level  of 300  BFU-E*/105  cells  or  ~3  X  10S/femur.  These  F-MuLV- 
induced  bursts,  BFU-E*,  differ  from the  BFU-E  in  uninfected  mice.  For example, 
although the morphology of the erythroid bursts  in the F-MuLV infected mice was 
similar  to that  in  the  uninfected  mice,  the  colonies were less  hemoglobinized  when 
compared with those in the uninfected mice. 
We  have  also  shown  that  if adult  BALB/c  or  DBA/2  mice  were  administered 
phenylhydrazine (PHZ), infection of cloned F-MuLV can induce certain erythropoi- 
etic  changes.  For example,  although  F-MuLV  alone  has  little  effect  on  the  spleen 
weights (0.1-0.15  g) of adult mice and PHZ can only moderately increase the spleen 
weights  (0.3  g),  infection  of F-MuLV  in  PHZ-treated  mice  can  induce  a  severe 
splenomegaly  (-1  g).  Similarly,  the  infection of F-MuLV in PHZ-treated  mice can 
also induce a  severe anemia and an increase in the frequency of CFU-E*. 
These results indicate that F-MuLV, without the SFFV components, can modulate 
erythropoesis  in  newborn  and  adult  mice.  The  finding  that  F-MuLV  in  newborn 
BALB/c mice elicit  very different  erythropoietic changes also has  interesting  impli- 
cations. The induction of a  dramatic  increase in BFU-E* with no increase  (possibly 
even  a  slight  decrease)  in  CFU-E*  implies  that  the  leukemic  block  in  F-MuLV- 
infected  newborn  mice  is  at  a  stage  between  BFU-E  and  CFU-E.  The  data  also 
suggest that F-MuLV infect different,  possibly more immature, erythroid target cells 
than the FLV complexes. 
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